Fresenius Medical Care AG (FMS) Cash from Restructuring (2009 - 2018)

Fresenius Medical Care AG's Cash from Restructuring history runs 6 years deep, the most recent figure standing at $51.4 million for Q4 2018.

• In Q4 2018, Cash from Restructuring fell 14.47% year-over-year to $51.4 million; the TTM figure through Dec 2018 stood at $51.4 million (down 14.47% YoY), while the FY2018 annual figure was $51.4 million, down 14.47% from the prior year.
• Cash from Restructuring for Q4 2018 stood at $51.4 million, down from $59.7 million in the prior quarter.
• The five-year high for Cash from Restructuring was $70.2 million in Q4 2016, with the low at $51.4 million in Q4 2018.
• The 3-year median for Cash from Restructuring is $60.0 million (2017), against an average of $60.9 million.
• The sharpest annual moves came in 2017 and 2018: Cash from Restructuring dropped 14.44% in 2017, then declined 14.47% in 2018.
• Fresenius Medical Care AG's Cash from Restructuring stood at $70.2 million in 2016, then slipped by 14.44% to $60.0 million in 2017, then retreated by 14.47% to $51.4 million in 2018.
• Business Quant data shows FMS's Cash from Restructuring at $51.4 million in Q4 2018, $59.7 million in Q2 2018, and $60.0 million in Q4 2017.